#Conference on Retroviruses and Opportunistic Infections

For those with fully suppressed HIV, switching to a two-drug regimen of cabotegravir and Edurant works as well taking a triple regimen.

Canadian research suggests rolling out Truvada as PrEP to prevent HIV would save money even if cost to treat the virus drops in the future.

Condomless receptive intercourse, ulcerative STIs, fisting and sharing sex toys are all linked with acquiring hepatitis C among HIV-posi...

Percentage of pregnant or breastfeeding mothers in three sub-Saharan African nations have viral loads high enough to pass HIV on babies.

The current standard protocols for anal cancer screenings may fail to adequately detect pre-cancerous lesions among women living with HIV.

HIV launches an immediate assault on the gut after infection, spurring inflammation and causing other damage that even very early antiretrovir...

A so-called TLR7 agonist has shown promise in its ability to wake infected cells from a dormant state and cause them to produce HIV.

People with HIV may experience body fat gains as a consequence of the virus rather than antiretrovirals.

New research underscores the great potential of Truvada as pre-exposure prophylaxis for preventing HIV among gay and bisexual men.

Researchers presented results from various studies on hepatitis C treatment and care at a medical conference in Seattle.

Levels of Selzentry (maraviroc) in vaginal and rectal tissues following a single dose were not high enough to be effective as PrEP in a recent...

People with HIV who take Viread, Norvir, Reyataz or Norvir-boosted Kaletra are at increasing risk of kidney disease over time.

For those coinfected with HIV, waiting to begin hepatitis C treatment until liver damage progresses raises the risk of liver-related complicat...

South Africa’s HIV-positive population has relatively low rates of engagement in health care and viral suppression

NY City is better linking people diagnosed with HIV into prompt medical care, as well as getting them treated and to full viral suppression.

People who coinfected with HIV and hepatitis C looking to take the HCV drug Olysio may need to change HIV medications to avoid drug-drug...